Cytotoxic properties of d-gluco-, d-galacto- and d-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells

European Journal of Medicinal Chemistry

Volumn 78, Issue , 2014, Pages 225-235

  Samadder, Pranati ^a   Xu, Yaozu ^a   Schweizer, Frank ^a,b   Arthur, Gilbert ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Department of Medical Microbiology ^*  (Canada)

Author keywords

Antitumor agents; Antitumor ether lipids; Breast cancer stem cells; Cationic lipids; Cytotoxicity; Glycolipids; Glycosylated antitumor ether lipids

Indexed keywords

2 AMINO 2 DEOXY GLYCEROLIPIDS; CYTOTOXIC AGENT; EDELFOSINE; GALACTOSE; GLUCOSE; GLYCEROLIPID; MANNOSE; SUGAR; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GLYCOLIPID;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; GOLD STANDARD; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOTHESIS; IN VITRO STUDY; PANCREAS CANCER; PROSTATE CANCER; REDUCTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GLYCOLIPIDS; HUMANS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84897448338     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.03.057     Document Type: Article

References (39)

1. World Cancer Research Fund International. http://www.wcrf.org/cancer- statistics/world-cancer-statistics.php.
2. L.R. Ferguson, and A.E. Pearson The clinical use of mutagenic anticancer drugs Mutation Research 355 1996 1 12
3. M. MacFarlane Cell death pathways-potential therapeutic targets Xenobiotica 39 2009 616 624
4. D.G. Kruh Introduction to resistance to anticancer agents Oncogene 22 2003 7262 7264
5. S.T. Wong, and S. Goodin Overcoming drug resistance in patients with metastatic breast cancer Pharmacotherapy 29 2009 954 965
6. D.B. Longley, and P.G. Johnston Molecular mechanisms of drug resistance Journal of Pathology 205 2005 275 292
7. S. Ma, T.K. Lee, B.J. Zheng, K.W. Chan, and X.Y. Guan CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway Oncogene 27 2008 1749 1758
8. G. Cassinelli, V. Zuco, L. Gatti, C. Lanzi, N. Zaffaroni, D. Colombo, and P. Perego Targeting the Akt kinase to modulate survival, invasiveness and drug resistance of cancer cells Current Medicinal Chemistry 20 2013 1923 1945
9. B.K. Garvalov, and T. Acker Cancer stem cells: a new framework for the design of tumor therapies Journal of Molecular Medicine 89 2011 95 107
10. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, and M. Guba et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323
11. A. Eramo, L. Ricci-Vitiani, A. Zeuner, R. Pallini, F. Lotti, and G. Sette et al. Chemotherapy resistance of glioblastoma stem cells Cell Death & Differentiation 13 2006 1238 1241
12. X. Li, M.T. Lewis, J. Huang, C. Gutierrez, C.K. Osborne, and M.F. Wu et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy Journal of the National Cancer Institute 100 2008 672 679
13. J. Chen, Y. Li, T.S. Yu, R.M. McKay, D.K. Burns, and S.G. Kernie et al. A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 2012 522 526
14. A.G. Schepers, H.J. Snippert, D.E. Stange, M. van den Born, J.H. van Es, and M. van de Wetering et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas Science 337 2012 730 735
15. G. Driessens, B. Beck, A. Caauwe, B.D. Simons, and C. Blanpain Defining the mode of tumor growth by clonal analysis Nature 488 2012 527 530
16. R. Zobalova, M. Stantic, M. Stapelberg, K. Prokopova, J. Dong, and J. Truksa et al. Drugs that kill cancer stem-like cells S. Shostak, Cancer Stem Cells Theories and Practice 2011 978-953-307-225-8
17. N. Facompre, H. Nakagawa, M. Herlyn, and D. Basu Stem-like cells and therapy resistance in squamous cell carcinomas Advances in Pharmacology 65 2012 235 265
18. H. Brachwitz, and C. Vollgraf Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells Pharmacology and Therapeutics 66 1995 39 82
19. R. Bittman, and G. Arthur Antitumor ether lipids: biological and biochemical effects A.S. Janoff, Liposomes: Rationale Design 1999 Marcell Dekker New York 125 144
20. G.A. Ruiter, S.F. Zerp, W.J. van Blitterswijk, and M. Verheij Alkyllysophospholipids activate the SAPK/JNK pathway and enhance radiation induced apoptosis Cancer Research 59 1999 2457 2463
21. 2-terminal kinase activation and c-jun in the induction of apoptosis by the ether lipid 1-O-octadecyl-2-O-methyl glycerophosphocholine Molecular Pharmacology 53 1998 602 612
22. L.A. Smets, H. Van Rooij, and G.S. Salmons Signaling steps in apoptosis by ether lipids Apoptosis 4 1999 419 427
23. P. Samadder, R. Bittman, H.S. Byun, and G. Arthur A glycosylated antitumor ether lipid kills cells by a paraptosis-like cell death Biochemistry and Cell Biology 87 2009 401 414
24. L. Jahreiss, M. Renna, R. Bittman, G. Arthur, and D.C. Rubinsztein 1-O-hexadecyl-2-O-methyl -3-O-(2″acetamido-2″-deoxy-β-D- glucopyranosyl)-sn-glycerol (Gln) induces cell death with more autophagosomes which is autophagy-independent Autophagy 5 2009 835 846
25. P. Samadder, H.S. Byun, R. Bittman, and G. Arthur The endocytosis pathway is required for the cytotoxic effects of glycosylated antitumor ether lipids Anticancer Research 31 2011 3809 3818
26. R.K. Erukulla, X. Zhou, P. Samadder, G. Arthur, and R. Bittman Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O- (2′-acetamido-2′-deoxy-β-D-glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-O-(2′-amino-2′-deoxy-β-D- glucopyranosyl)-sn-glycerol on epithelial cancer cell growth Journal of Medicinal Chemistry 39 1996 1541 1554
27. G. Yang, R.W. Franck, R. Bittman, P. Samadder, and G. Arthur Synthesis and growth-inhibitory properties of glucosamine-derived glycerolipids Organic Letters 3 2001 197 200
28. Y. Xu, M. Ogunsina, P. Samadder, G. Arthur, and F. Schweizer Structure-activity relationships of glucosamine-derived glycerolipids: the role of the anomeric linkage, the cationic charge and the glycero moiety on the antitumor activity ChemMedChem 8 2013 511 520
29. G. Arthur, and R. Bittman Glycosylated antitumor ether lipids: activity and mechanism of action Anti-Cancer Agents in Medicinal Chemistry 2014 (in press)
30. I. Garcia-Alvarez, H. Groult, J. Casas, M.A. Barred-Manso, N. Yanguas-Casas, M. Nieto-Sampedro, L. Romero-Ramirez, and A. Fernandez-Mayoralas Synthesis and antimitotic thioglycosides: in vitro and in vivo evaluation of their anticancer activity Journal of Medicinal Chemistry 54 2011 6949 6955
31. L. Guazzelli, G. Catelani, F.D. Andrea, and A. Gainnarelli Stereoselective entry into the D GalNac series starting from the D-Gal one: a new access to N-acetyl-D-galactosamine and derivatives thereof Carbohydrate Research 344 2009 298 303
32. A.K. Balcerzak, S.S. Ferreira, J.F. Trant, and R.N. Ben Structurally diverse disaccharide analogs of antifreeze glycoproteins and their ability to inhibit ice recrystallization Bioorganic & Medicinal Chemistry Letters 22 2012 1719 1721
33. E.Y. Lasfargues, W.G. Coutinho, and A.S. Dion A human breast tumor cell line (BT-474) that supports mouse mammary tumor virus replication In Vitro 15 1979 723 729
34. C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, and M. Brown et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1 2007 555 567
35. E. Charafe-Jauffret, C. Ginestier, F. Lovino, J. Wiccans, N. Cervera, and P. Finetti et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and distinct molecular signature Cancer Research 69 2009 1302 1313
36. A.K. Croker, D. Goodale, C. Postenka, D.B. Hedley, and D. Hess High aldehyde dehydrogenase and expression of cancer cell markers select for breast cancer cells with enhanced malignant and metastatic ability Journal of Cellular and Molecular Medicine 13 2009 2236 2252
37. A. Noseda, M.E. Berens, C. Piantadosi, and E.J. Modest Neoplastic cell inhibition with new ether lipid analogs Lipids 22 1987 878 883
38. D.B.J. Hermann, E. Besenfelder, U. Bicher, W. Pahlke, and E. Bohm Pharmacokinetics of the thioether phospholipid analogue BM41.440 in rats Lipids 22 1987 952 954
39. J.V.D.B. Leendert, A.D. Boudewijn, C.D.K. Martijin, V.F. Dmitri, S.O. Herman, and A.V.D.M. Gijsbert Study of the glycosidation properties of 1-thiomannosazidopyranosides and 1-thiomannosaziduronic acid esters European Journal of Organic Chemistry 1 2007 116 124